Company News

Dr. José Luis Zamorano and Dr. Eliseo Vañó Galván Speak on MyoStrain® Following Cardiology Summit Forum in Madrid 

December 20, 2021
Company News

MORRISVILLE, N.C., December 20, 2021 – Dr. Eliseo Vañó Galván and Dr. José Luis Zamorano were interviewed by reporters from the General Council of Nursing in Spain for the Nurse Channel (Canal Enfermero), the council’s news outlet on health and medical professional topics with over 70,000 subscribers internationally.

Dr. Eliseo Vañó Galván is the medical director of Magnetic Resonance and CT of the Hospital Nuestra Señora del Rosario in the capital. Dr. José Luis Zamorano is the head of the Cardiology Service of the Ramón y Cajal University Hospital in Madrid and vice president of the European Society of Cardiology.  

Dr. Galván and Dr. Zamorano have both had experience evaluating MyoStrain clinically and speak to the benefits and promise of the technology, highlighting its utility across patient and disease type that will transform cardiac care in Spain.

Watch the video with English subtitles here: https://vimeo.com/656638318  

Watch the original Spanish-only video here: https://www.youtube.com/watch?v=X0LXNadpqhE  

Media Contact

Taylor Solomon
PR@myocardialsolutions.com
919.623.0973

About Myocardial Solutions, Inc.

Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 500 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, non-invasive MRI heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.

To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.